相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer
Fumine Tsukamoto et al.
BMC CANCER (2021)
Development and validation of a nomogram to predict drainage duration in patients with breast cancer treated with modified radical mastectomy
Song Wu et al.
SCIENTIFIC REPORTS (2021)
The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis
Ke Wang et al.
BMC CANCER (2021)
Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
Leqian Guo et al.
BMC CANCER (2021)
A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients
Angeline Ginzac et al.
BMC CANCER (2020)
Postmastectomy radiation therapy in early breast cancer: Utility or futility?
Angel Montero et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Adjuvant chemotherapy in small node-negative triple-negative breast cancer
Tessa G. Steenbruggen et al.
EUROPEAN JOURNAL OF CANCER (2020)
Adjuvant chemotherapy for small, lymph node-negative, triple-negative breast cancer: A single-center study and a meta-analysis of the published literature
Xin An et al.
CANCER (2020)
Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis
Zhao-hua Gao et al.
BMC CANCER (2020)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors
Carol A. Parise et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G. Curigliano et al.
ANNALS OF ONCOLOGY (2017)
Impact of adjuvant chemotherapy on survival of women with T1N0M0, hormone receptor negative breast cancer
Nanthini Thevi Bhoo-Pathy et al.
CANCER EPIDEMIOLOGY (2017)
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment
Oleg Gluz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
H. Gilbert Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Designing and Psychometric Evaluation of Adjustment to Illness Measurement Inventory for Iranian Women With Breast Cancer
Sepideh Hajian et al.
IRANIAN JOURNAL OF CANCER PREVENTION (2016)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
E. Senkus et al.
ANNALS OF ONCOLOGY (2015)
Long term side effects of adjuvant chemotherapy in patients with early breast cancer
Jessica J. Tao et al.
BREAST (2015)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Spectrum of very early breast cancer in a setting without organised screening
N. Bhoo-Pathy et al.
BRITISH JOURNAL OF CANCER (2014)
New Strategies in Breast Cancer: The Significance of Molecular Subtypes in Systemic Adjuvant Treatment for Small T1a,bN0M0 Tumors
Amir Sonnenblick et al.
CLINICAL CANCER RESEARCH (2014)
Breast Cancer: A World of Differences
Kelly Servick
SCIENCE (2014)
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
Peter C. Austin
PHARMACEUTICAL STATISTICS (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence
K. -J. Winzer et al.
EUROPEAN JOURNAL OF CANCER (2010)
Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort
Sarah F. Marshall et al.
BREAST CANCER RESEARCH (2010)
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features
Lori J. Goldstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Development of the 21-gene assay and its application in clinical practice and clinical trials
Joseph A. Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Weekly paclitaxel in the adjuvant treatment of breast cancer
Joseph A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients
Timothy Kennedy et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study
JA Petrek et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effect of screening and adjuvant therapy on mortality from breast cancer
DA Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States
M Schootman et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis
BF Cole et al.
LANCET (2001)
分享论文
